Epigenetics and ncRNAs in Brain Function and Disease: Mechanisms and Prospects for Therapy

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neurotherapeutics

• Publication date

  2013-09-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13311-013-0212-7PMID 24068583PMCID PMC3805859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2

  2013cited by this paper
• Treatment of HCV infection by targeting microRNA.

  2013cited by this paper
• Hypermethylation and Post-Transcriptional Regulation of DNA Methyltransferases in the Ovarian Carcinomas of the Laying Hen

  2013cited by this paper
• Therapeutic targeting of non-coding RNAs.

  2013cited by this paper
• Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma

  2013cited by this paper
• miR‐370 is stage‐specifically expressed during mouse embryonic development and regulates Dnmt3a

  2013cited by this paper
• Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR-483-5p.

  2013cited by this paper
• microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis

  2013cited by this paper
• Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities

  2013cited by this paper
• MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice.

  2013cited by this paper
• MicroRNA miR-29c Down-Regulation Leading to De-Repression of Its Target DNA Methyltransferase 3a Promotes Ischemic Brain Damage

  2013cited by this paper
• MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer

  2013cited by this paper
• Approaches to manipulating microRNAs in neurogenesis

  2013cited by this paper
• Bortezomib‐induced sensitization of malignant human glioma cells to vorinostat‐induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl‐1 cleavage, and DNA damage

  2013cited by this paper
• Transgenerational epigenetic inheritance: how important is it?

  2013cited by this paper
• Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer

  2013cited by this paper
• Role of noncoding RNAs in trinucleotide repeat neurodegenerative disorders.

  2012cited by this paper
• Circulating microRNAs involved in multiple sclerosis

  2012cited by this paper
• MicroRNA Regulation of the Synaptic Plasticity-Related Gene Arc

  2012cited by this paper
• miR-34 – a microRNA replacement therapy is headed to the clinic

  2012cited by this paper
• MicroRNAs in cancers and neurodegenerative disorders

  2012cited by this paper
• miR-886-3p Levels Are Elevated in Friedreich Ataxia

  2012influential reference
• Natural Antisense Makes Sense for Gene-specific Activation in Brain

  2012cited by this paper
• An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration

  2012cited by this paper
• Epigenetic control of alternative mRNA processing at the imprinted Herc3/Nap1l5 locus

  2012cited by this paper
• MicroRNA-218 Inhibits Cell Cycle Progression and Promotes Apoptosis in Colon Cancer by Downregulating BMI1 Polycomb Ring Finger Oncogene

  2012cited by this paper
• Cause or Effect: Misregulation of microRNA Pathways in Neurodegeneration

  2012cited by this paper
• Repressor element-1 silencing transcription factor (REST)-dependent epigenetic remodeling is critical to ischemia-induced neuronal death

  2012cited by this paper
• The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming

  2012cited by this paper
• MicroRNAs in Parkinson's disease.

  2012cited by this paper
• High-Throughput Luciferase Reporter Assay for Small-Molecule Inhibitors of MicroRNA Function

  2012cited by this paper
• Plasma components affect accuracy of circulating cancer-related microRNA quantitation.

  2012cited by this paper
• The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells.

  2012cited by this paper
• Epigenetic regulation of human cis-natural antisense transcripts

  2012cited by this paper
• miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eµ-miR-155 transgenic mouse model

  2012cited by this paper
• Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study.

  2012cited by this paper
• miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression

  2012cited by this paper
• Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation

  2012cited by this paper
• MicroRNA-223 is neuroprotective by targeting glutamate receptors

  2012cited by this paper
• Synergetic Cooperation of microRNAs with Transcription Factors in iPS Cell Generation

  2012cited by this paper
• Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo.

  2012cited by this paper
• Epigenetic cancer therapy: rationales, targets and drugs

  2012cited by this paper
• Let-7a inhibits proliferation and induces apoptosis by targeting EZH2 in nasopharyngeal carcinoma cells.

  2012cited by this paper
• MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship

  2012cited by this paper
• Chemically Modified Oligonucleotides Modulate an Epigenetically Varied and Transient Form of Transcription Silencing of HIV-1 in Human Cells

  2012influential reference
• Targeting Huntington’s disease through histone deacetylases

  2011cited by this paper
• Genetic Markers for PTSD Risk and Resilience Among Survivors of the World Trade Center Attacks

  2011cited by this paper
• An Optimized Sponge for microRNA miR-9 Affects Spinal Motor Neuron Development in vivo

  2011cited by this paper
• The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2

  2011cited by this paper
• Silencing of microRNA families by seed-targeting tiny LNAs

  2011influential reference
• microRNA-450a targets DNA methyltransferase 3a in hepatocellular carcinoma.

  2011cited by this paper
• A specific miRNA signature in the peripheral blood of glioblastoma patients

  2011cited by this paper
• MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1

  2011cited by this paper
• Polycomb proteins in mammalian cell differentiation and plasticity

  2011cited by this paper
• miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells.

  2011cited by this paper
• microRNAs modulate iPS cell generation.

  2011cited by this paper
• Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1.

  2011cited by this paper
• MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

  2011cited by this paper
• Altered microRNA regulation in Huntington's disease models.

  2011cited by this paper
• MicroRNA function in the nervous system.

  2011cited by this paper
• Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters

  2011cited by this paper
• Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

  2011cited by this paper
• Upregulation of MiR-155 in Nasopharyngeal Carcinoma is Partly Driven by LMP1 and LMP2A and Downregulates a Negative Prognostic Marker JMJD1A

  2011cited by this paper
• Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing

  2011cited by this paper
• MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.

  2010cited by this paper
• Cross talk between microRNA and epigenetic regulation in adult neurogenesis

  2010cited by this paper
• Inhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy

  2010cited by this paper
• Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection

  2010cited by this paper
• MicroRNA 128a Increases Intracellular ROS Level by Targeting Bmi-1 and Inhibits Medulloblastoma Cancer Cell Growth by Promoting Senescence

  2010cited by this paper
• Epigenetics in cancer.

  2010cited by this paper
• Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma.

  2010cited by this paper
• DNA methylation in glioblastoma: impact on gene expression and clinical outcome

  2010cited by this paper
• Regulation of Alternative Splicing by Histone Modifications

  2010cited by this paper
• MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction

  2009cited by this paper
• Efficient Regulation of VEGF Expression by Promoter-Targeted Lentiviral shRNAs Based on Epigenetic Mechanism: A Novel Example of Epigenetherapy

  2009cited by this paper
• MicroRNAs: key regulators of stem cells

  2009cited by this paper
• Embryonic stem cell–specific microRNAs promote induced pluripotency

  2009cited by this paper
• Transcriptional inhibiton of Hoxd4 expression by miRNA-10a in human breast cancer cells

  2009cited by this paper
• The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2.

  2009cited by this paper
• Transgenic microRNA inhibition with spatiotemporal specificity in intact organisms

  2009cited by this paper
• Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells.

  2009cited by this paper
• miR-124 regulates adult neurogenesis in the SVZ stem cell niche

  2009cited by this paper
• RNA regulation of epigenetic processes

  2009cited by this paper
• Molecular epigenetics and genetics in neuro-oncology

  2009cited by this paper
• miR-449a targets HDAC-1 and induces growth arrest in prostate cancer

  2009cited by this paper
• MicroRNA Profiling of Human-Induced Pluripotent Stem Cells

  2009cited by this paper
• Mobilization-competent Lentiviral Vector-mediated Sustained Transcriptional Modulation of HIV-1 Expression.

  2009cited by this paper
• Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription.

  2009cited by this paper
• The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

  2009cited by this paper
• MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.

  2009cited by this paper
• Persistent epigenetic differences associated with prenatal exposure to famine in humans

  2008cited by this paper
• Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers

  2008cited by this paper
• MeCP2 binding to DNA depends upon hydration at methyl-CpG.

  2008cited by this paper
• Small-molecule inhibitors of microrna miR-21 function.

  2008cited by this paper
• Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.

  2008cited by this paper
• NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma.

  2008cited by this paper
• MicroRNA-373 induces expression of genes with complementary promoter sequences

  2008cited by this paper
• MicroRNAs accurately identify cancer tissue origin

  2008cited by this paper
• A small molecule enhances RNA interference and promotes microRNA processing

  2008cited by this paper
• miR-148 targets human DNMT3b protein coding region.

  2008cited by this paper

• MiR-27b-3p Reduces the Efficacy of Propranolol in the Treatment of Infantile Hemangioma by Inhibiting the Expression of Apaf-1

  2025cites this paper
• Parkinson's Disease and Cancer: Mechanistic Insights and Therapeutic Opportunities From Cancer Neuroscience

  2025cites this paper
• The Epigenetic Tapestry: A Review of DNA Methylation and Non-Coding RNA's Interplay with Genetic Threads, Weaving a Network Impacting Gene Expression and Disease Manifestations

  2025cites this paper
• Exploring epigenetic modifications as potential biomarkers and therapeutic targets in amyotrophic lateral sclerosis

  2025cites this paper
• Circulating epigenetic signatures classifying brain insulin resistance in humans.

  2025cites this paper
• New Generation of Clinical Epigenetics Analysis and Diagnosis for Precision Medicine

  2025cites this paper
• Recent Advances in the miRNA-Mediated Regulation of Neuronal Differentiation and Death

  2024cites this paper
• Functional roles, regulatory mechanisms and theranostics applications of ncRNAs in alcohol use disorder

  2023cites this paper
• Extracellular Vesicle MicroRNAs in Heart Failure: Pathophysiological Mediators and Therapeutic Targets

  2023cites this paper
• Epigenetics in inflammatory liver diseases: A clinical perspective (Review)

  2022cites this paper
• MicroRNA-193a-5p Rescues Ischemic Cerebral Injury by Restoring N2-Like Neutrophil Subsets

  2022cites this paper
• Analysis of the Epigenetic Mechanism and Treatment of Huntington’s Disease

  2022cites this paper
• Altered TDP-43 Structure and Function: Key Insights into Aberrant RNA, Mitochondrial, and Cellular and Systemic Metabolism in Amyotrophic Lateral Sclerosis

  2022cites this paper
• Dark DNA and stress (Review)

  2022cites this paper
• Genetic and epigenetic mechanisms influencing acute to chronic postsurgical pain transitions in pediatrics: Preclinical to clinical evidence

  2022cites this paper
• NDT_A_242040 597..606

  2020cites this paper
• The Potential Role of Epigenetic Drugs in the Treatment of Anxiety Disorders

  2020cites this paper
• Epigenetic upregulation of acid-sensing ion channel 1 contributes to gastric hypersensitivity in adult offspring rats with prenatal maternal stress.

  2019cites this paper
• Recent Advancements in Bipolar Disorder studies through Genomic, Epigenomic and Metagenomic Approaches

  2019cites this paper
• A Not So Benign Family Pedigree With Hereditary Chorea: A Broader Phenotypic Expression or Additional Picture?

  2019cites this paper
• Epigenetic Modulation of Visceral Pain

  2019cites this paper
• MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines

  2019cites this paper
• Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer’s and Parkinson’s Diseases

  2018cites this paper
• Epigenetics and bone diseases

  2018cites this paper
• The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in Hepatitis B Patients

  2018cites this paper
• Do MicroRNAs Modulate Visceral Pain?

  2018cites this paper
• A role for activity‐dependent epigenetics in the development and treatment of major depressive disorder

  2018cites this paper
• The correlation between DNA methylation and transcriptional expression of human dopamine transporter in cell lines.

  2018cites this paper
• Cav-1 promote lung cancer cell proliferation and invasion through lncRNA HOTAIR.

  2018cites this paper
• Molecular Windows into the Human Brain for Psychiatric Disorders

  2018cites this paper
• Epigenetics and bone diseases.

  2018cites this paper
• Epigenetics in Chronic Pain

  2017cites this paper
• Psychiatric Pharmacogenomics: How to Integrate into Clinical Practice

  2017cites this paper
• Pharmacogenetic considerations in the treatment of Alzheimer's disease.

  2016cites this paper
• Fingerprinting of neurotoxic compounds using a mouse embryonic stem cell dual luminescence reporter assay

  2016cites this paper
• Chapter 32 – Pharmacoepigenomics

  2016cites this paper
• Novel Therapeutic Strategies for Dementia.

  2016cites this paper
• Basic Principles of Noncoding RNAs in Epigenetics

  2016cites this paper
• Searching for convergent pathways in autism spectrum disorders: insights from human brain transcriptome studies

  2016cites this paper
• Epigenetic regulation of persistent pain.

  2015cites this paper
• MicroRNAs: newcomers into the ALS picture.

  2015cites this paper
• Therapeutic perspectives of epigenetically active nutrients

  2015cites this paper
• Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer

  2015cites this paper
• MicroRNA Regulation of Brain Tumour Initiating Cells in Central Nervous System Tumours

  2015cites this paper
• Pharmacoepigenomics and the Metabolomics of Drug Efficacy and Safety

  2015cites this paper
• Epigenetic mechanisms: A possible link between autism spectrum disorders and fetal alcohol spectrum disorders.

  2015cites this paper
• Epigenetics and Personalized Pain Management

  2015cites this paper
• Epigenetic drug discovery for Alzheimer’s disease

  2014cites this paper
• The role of long non-coding RNAs in neurodevelopment, brain function and neurological disease

  2014cites this paper
• Epigenomic Networking in Drug Development: From Pathogenic Mechanisms to Pharmacogenomics

  2014cites this paper
• The role of epigenetic-related codes in neurocomputation: dynamic hardware in the brain

  2014cites this paper
• The synthesis and application of a diazirine-modified uridine analogue for investigating RNA–protein interactions

  2014cites this paper
• Epigenetic upregulation of metabotropic glutamate receptor 2 in the spinal cord attenuates oestrogen-induced visceral hypersensitivity

  2014cites this paper
• Looking Above but Not Beyond the Genome for Therapeutics in Neurology and Psychiatry: Epigenetic Proteins and RNAs Find a New Focus

  2013cites this paper